Healing a Sick System: From Big Pharma to Our Pharma

Imagine a world in which insulin and PrEP—the revolutionary one-a-day preventative HIV pill—were available to all who needed them at prices they could easily afford. Imagine that the effective Lyme disease vaccine once available was still on the market, and that new drugs consistently provided new clinical benefits, not just new prices.

In this world, there would be no artificial scarcity of COVID-19 vaccines, therapeutics, or tests needlessly prolonging the pandemic and upping the body count. Pharmaceutical manufacturing plants would be considered critical infrastructure, and retail pharmacies would be run for the benefit of their workers and local communities.

That world is eminently possible, and it could be built from a foundation of democratic, public ownership in the pharmaceutical sector. 

Previous
Previous

As Sen. Joe Manchin fought federal spending, his daughter helped shutter a union drug plant

Next
Next

Healthcare as a public service: Redesigning U.S. healthcare with health and equity at the center